DK0625351T3 - Use of etofibrate and pharmaceutical preparations containing etofibrate for the treatment of diabetic angio- and retinopathy - Google Patents

Use of etofibrate and pharmaceutical preparations containing etofibrate for the treatment of diabetic angio- and retinopathy

Info

Publication number
DK0625351T3
DK0625351T3 DK94106819T DK94106819T DK0625351T3 DK 0625351 T3 DK0625351 T3 DK 0625351T3 DK 94106819 T DK94106819 T DK 94106819T DK 94106819 T DK94106819 T DK 94106819T DK 0625351 T3 DK0625351 T3 DK 0625351T3
Authority
DK
Denmark
Prior art keywords
etofibrate
retinopathy
treatment
pharmaceutical preparations
preparations containing
Prior art date
Application number
DK94106819T
Other languages
Danish (da)
Inventor
Hans Dr Med Erbler
Original Assignee
Merz & Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co
Application granted granted Critical
Publication of DK0625351T3 publication Critical patent/DK0625351T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Abstract

The present invention relates to the use of etofibrate for the treatment of diabetic angiopathy and retinopathy and to pharmaceutical compositions which contain etofibrate in the form of pellets and which are particularly suitable for the abovementioned indication.
DK94106819T 1993-05-19 1994-05-02 Use of etofibrate and pharmaceutical preparations containing etofibrate for the treatment of diabetic angio- and retinopathy DK0625351T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4317127A DE4317127A1 (en) 1993-05-19 1993-05-19 Use of etofibrate and pharmaceutical compositions containing etofibrate for the treatment of diabetic angio-and retinopathy

Publications (1)

Publication Number Publication Date
DK0625351T3 true DK0625351T3 (en) 1999-08-30

Family

ID=6488713

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94106819T DK0625351T3 (en) 1993-05-19 1994-05-02 Use of etofibrate and pharmaceutical preparations containing etofibrate for the treatment of diabetic angio- and retinopathy

Country Status (7)

Country Link
EP (1) EP0625351B1 (en)
AT (1) ATE175349T1 (en)
DE (2) DE4317127A1 (en)
DK (1) DK0625351T3 (en)
ES (1) ES2126015T3 (en)
GR (1) GR3029898T3 (en)
SI (1) SI0625351T1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005002541A2 (en) * 2003-07-02 2005-01-13 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1941217C3 (en) * 1969-08-13 1974-06-12 Merz & Co, 6000 Frankfurt Alpha square brackets on 2- (p-chlorophenoxy) -isobutyryril square brackets on-beta-nicotinoylglycol ester and process for its preparation
IT1180507B (en) * 1984-06-29 1987-09-23 Roberto Valducci PROCEDURE FOR THE PREPARATION OF ETOFIBRATE OR SUBSTANCES OF EQUAL OR SIMILAR CHARACTERISTICS, IN MICROGUNULI-DELAY AND PRODUCT OBTAINED WITH SUCH PROCEDURE
DE3621861A1 (en) * 1986-06-30 1988-01-14 Laszlo Dr Med Ilg USE OF ARYLOXYCARBONIC ACID DERIVATIVES AGAINST DERMATOLOGICAL DISEASES
DE4021678C2 (en) * 1990-07-07 1994-07-07 Merz & Co Gmbh & Co Process for the preparation of small-sized shaped articles with a high etofibrate content and controlled release of active ingredient, their use and existing orally administrable administration forms

Also Published As

Publication number Publication date
DE59407576D1 (en) 1999-02-18
DE4317127A1 (en) 1994-11-24
ES2126015T3 (en) 1999-03-16
EP0625351A1 (en) 1994-11-23
EP0625351B1 (en) 1999-01-07
GR3029898T3 (en) 1999-07-30
ATE175349T1 (en) 1999-01-15
SI0625351T1 (en) 1999-04-30

Similar Documents

Publication Publication Date Title
DK552684A (en) DESULPHATO HIRUDINES AND THEIR PREPARATION AND USE
DE68912237D1 (en) Vapor-sensitive composition and sterilization-indicating composition containing it.
NO177374C (en) Stable preparations of fat-soluble substances and the use of fish gelatin in their preparation
SE8700498D0 (en) NOVEL PHARMACEOLOGICALLY ACTIVE COMPOUNDS
DK573384D0 (en) SPHINGOSIN DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES
ATE101517T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING LORATADIN, IBUPROFEN AND PSEUDOEPHEDRIN.
DE69015842T2 (en) Nicotinic acid derivatives and pharmaceutical compositions containing them.
DE69014351T2 (en) Pyridinecarboxamide derivatives and pharmaceutical compositions containing them.
NO972391D0 (en) 2-Substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and their preparations and methods
NO921382D0 (en) AMIDINOPHENYLALANINE DERIVATIVES, AS PREPARATION, USE AND PREPARATIONS CONTAINING THE COMPOUNDS
IL98917A0 (en) Piperidyl ethers and thioethers and their use as inhibitors of cholesterol biosynthesis
DE3583765D1 (en) HYDANTO DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DK47885D0 (en) COMPOSITIONS FOR USE AS COSMETIC, HEALTHCARE AND BODY PROTECTIVE AGENTS
DE68921908T2 (en) Cell-associated glucosyltransferase, antibodies against it and a composition containing it for the prophylaxis of caries.
DE69216188T3 (en) Cosmetics and pharmaceuticals containing extensin
DE69224836T2 (en) OPTICALLY ACTIVE TETRAHYDROPYRAN DERIVATIVES, LIQUID CRYSTAL COMPOSITIONS AND LIQUID CRYSTAL ELEMENTS CONTAINING THEM
DK0625351T3 (en) Use of etofibrate and pharmaceutical preparations containing etofibrate for the treatment of diabetic angio- and retinopathy
DE68905973T2 (en) SYNERGISTIC FOOD COMPOSITIONS CONTAINING CHLORODEOXYSUCRASE, AND COMPOSITIONS THEREOF.
DE3068880D1 (en) Carbamates, their preparation and pharmaceutical compositions containing them
DK78788D0 (en) 4-SUBSTITUTED BENZAMIDE DERIVATIVES AND PHARMACEUTICAL AGENTS CONTAINING SUCH DERIVATIVES
DK330687A (en) RELATIONS AND PHARMACEUTICAL COMPOSITIONS USED AS CARDIOTONIC AGENTS
DE59101818D1 (en) Pharmaceutical preparation containing stigmasta-4-en-3-one and their use.
FR2707492B1 (en) New cosmetic or dermatological compositions containing the ribosomes, preparation of the ribosomes, preparation of the said compositions and their application.
JPS5748915A (en) Tumor inhibiting pharmaceutical composition and use thereof
NO934700D0 (en) Abrin variants, abrin immunotoxins and pharmaceutical compositions containing these